Analysed BridgeBio Oncology Therapeutics Inc (BBOT:NASDAQ) News Sources
BBOT Announces Publication in Cancer Discovery Highlighting Preclinical Data Demonstrating BBO-11818 is a Potent and Selective panKRAS Inhibitor
Yahoo Finance
BBOT Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress
Yahoo Finance
Hematologic Malignancies Market to Reach USD 128.48 Billion by 2032, Driven by Immunotherapy, CAR-T, and Precision Oncology - Credence Research Inc.
MarketWatch
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cogent Biosciences (COGT), Aquestive Therapeutics (AQST) and Merck & Company (MRK)
The Globe and Mail
What is the current price of BridgeBio Oncology Therapeutics Inc (BBOT:NASDAQ)?
The current price of BridgeBio Oncology Therapeutics Inc (BBOT:NASDAQ) is $10.42.
BridgeBio Oncology Therapeutics Inc (BBOT:NASDAQ) absolute price change since previous trading day?
The absolute price change of BridgeBio Oncology Therapeutics Inc (BBOT:NASDAQ) since the previous trading day is $0.53.
BridgeBio Oncology Therapeutics Inc (BBOT:NASDAQ) percentage price change since previous trading day?
The percentage price change of BridgeBio Oncology Therapeutics Inc (BBOT:NASDAQ) since the previous trading day is 5.36%.
What is This Week's average sentiment score for BridgeBio Oncology Therapeutics Inc (BBOT:NASDAQ)?
This Week's average sentiment score for BridgeBio Oncology Therapeutics Inc (BBOT:NASDAQ) is 76 out of 100.
What is This Week's average sentiment for BridgeBio Oncology Therapeutics Inc (BBOT:NASDAQ)?
This Week's sentiment for BridgeBio Oncology Therapeutics Inc (BBOT:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.